Pison, a Boston, MA-based developer of AI-powered neural sensors for cognitive health, wellness, and gesture control, received an investment from Samsung Ventures.
The amount of the deal was not disclosed.
The company intends to use the funds to improve its neurocognitive assessment and tracking capabilities.
Led by CEO John Croteau, Pison has developed innovative sensor technology that detects brain activity from three nerve bundles in the wrist. Using both active and passive AI algorithms, it extracts neurocognitive data, providing insights into mental acuity and impairment from poor sleep, chronic fatigue, anxiety, neurodegenerative conditions, drugs, alcohol, and subconcussive brain injuries. With it, users gain access to better health and higher achievement in every domain while reaching peak mental and physical performance on the playing field, at work, and in everyday life.
The company was founded in 2016 with funding from the Massachusetts Institute of Technology, National Science Foundation, and the ALS Association. It has also received funding from several Small Business Innovation Research (SBIR) awards from the U.S. Department of Defense, and various research institutions. In addition, the FY2025 National Defense Authorization Act (NDAA) highlights the value of neural biosensors for advancing warfighter health and readiness, namely detecting traumatic brain injuries and tracking chronic fatigue.
FinSMEs
07/01/2024